Kes, M. (2026). hENT Inhibition Prevents Pyrimidine-Driven Resistance to DHODH Inhibition in Malignant Rhabdoid Tumors. Zenodo.
Chicago Style (17th ed.) CitationKes, Marjolein. HENT Inhibition Prevents Pyrimidine-Driven Resistance to DHODH Inhibition in Malignant Rhabdoid Tumors. Zenodo, 2026.
MLA (9th ed.) CitationKes, Marjolein. HENT Inhibition Prevents Pyrimidine-Driven Resistance to DHODH Inhibition in Malignant Rhabdoid Tumors. Zenodo, 2026.
Warning: These citations may not always be 100% accurate.